Bio-Rad Laboratories, Inc. (BIO) News

Bio-Rad Laboratories, Inc. (BIO): $421.93

3.38 (+0.81%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Filter BIO News Items

BIO News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

BIO News Highlights

  • BIO's 30 day story count now stands at 4.
  • Over the past 7 days, the trend for BIO's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about BIO are PDCO.

Latest BIO News From Around the Web

Below are the latest news stories about BIO-RAD LABORATORIES INC that investors may wish to consider to help them evaluate BIO as an investment opportunity.

Patterson Companies (PDCO) Q1 Earnings & Sales Miss Estimates

Patterson Companies' (PDCO) fiscal first-quarter 2023 results were adversely impacted by unfavorable currency movements.

Yahoo | September 1, 2022

Cooper Companies (COO) Q3 Earnings & Revenues Top Estimates

Despite a decline in the bottom line, Cooper Companies' (COO) fiscal third-quarter earnings reflect solid segmental performance.

Yahoo | September 1, 2022

What's in Store for Patterson Companies (PDCO) in Q1 Earnings?

Patterson Companies' (PDCO) fiscal first-quarter results are likely to reflect an improvement at the Animal Health segment.

Yahoo | August 29, 2022

Cooper Companies (COO) to Post Q3 Earnings: What's in Store?

Cooper Companies' (COO) fiscal third-quarter results are likely to reflect segmental strength.

Yahoo | August 25, 2022

Here's Why You Should Invest in Bio-Rad (BIO) Stock Now

Investors are optimistic about Bio-Rad's (BIO) better-than-expected results and continued growth across major geographies.

Yahoo | August 22, 2022

4 Stocks to Watch Amid Recovering Medical Products Industry

Despite the COVID-induced challenges, rising demand for IVD coupled with dependence on AI & Robotics should lend support to the Zacks Medical-Products industry. ZBH, BIO, LNTH and HAE are well-poised to gain from the favorable factors.

Yahoo | August 18, 2022

Levin Easterly Partners’ Latest Portfolio: Top 10 Stock Picks

This article discusses the top 10 stock picks of Levin Easterly Partners at the end of the second quarter of 2022. If you want to jump ahead and learn about the firm’s top five favourite stocks, please go to Levin Easterly Partners’ Latest Portfolio: Top 5 Stock Picks. Levin Easterly Partners traces its origin back […]

Yahoo | August 15, 2022

12 Best Healthcare Stocks To Buy Now

In this piece, we will take a look at the twelve best healthcare stocks to buy now. If you want to skip the details and head on to the top stocks in this list, then take a look at 5 Best Healthcare Stocks To Buy Now. Healthcare stocks are proving to be resilient in the […]

Yahoo | August 4, 2022

Bio-Rad Acquires Curiosity Diagnostics

HERCULES, Calif., August 03, 2022--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader in life science research and clinical diagnostic products, announced today that it has reached an agreement to acquire all of the outstanding shares of Curiosity Diagnostics, Sp. Z. o. o. from Scope Fluidics, S.A. (WSE NewConnect: SCP), a Warsaw, Poland, based developer of innovative technology solutions for the medical diagnostic and healthcare markets, for a total consideration of up to $170 mil

Yahoo | August 3, 2022

Bio-Rad (BIO) Q2 Earnings Surpass Estimates, Gross Margin Up

Overall demand for Bio-Rad's (BIO) Life Science and Clinical Diagnostics continues to be strong on localized surges of COVID-19.

Yahoo | July 29, 2022


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.4924 seconds.